The T7-ASO-lipid nanoparticles decreased the expression of Bcl2 and Akt-1in LC cell lines, exhibited superior antitumor effects, and improved the overall survival (OS) in LC xenograft bearing mice [224]. Here, BCL2 is linked to laryngotracheoesophageal cleft.